Rieko Tadokoro-Cuccaro
Overview
Explore the profile of Rieko Tadokoro-Cuccaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patjamontri S, Lucas-Herald A, Bryce J, van den Akker E, Cools M, Globa E, et al.
J Clin Endocrinol Metab
. 2024 Aug;
PMID: 39213311
Introduction: Partial androgen insensitivity syndrome (PAIS) is a rare condition that is reported to be commonly associated with gynecomastia in males. Objectives: To assess the management of gynecomastia in male...
2.
Guaragna-Filho G, Guerra-Junior G, Tadokoro-Cuccaro R, Hughes I, Barros B, Hiort O, et al.
Sex Dev
. 2023 Mar;
17(1):16-25.
PMID: 36917969
Introduction: Although it was common in the 1970s-1990s to assign female gender of rearing to 46,XY infants with limited virilization of varying etiologies, including those with partial androgen insensitivity syndrome...
3.
Lawrence N, Bacila I, Dawson J, Bryce J, Ali S, van den Akker E, et al.
Clin Endocrinol (Oxf)
. 2022 Jul;
97(5):551-561.
PMID: 35781728
Objective: Congenital adrenal hyperplasia (CAH) requires exogenous steroid replacement. Treatment is commonly monitored by measuring 17-OH progesterone (17OHP) and androstenedione (D4). Design: Retrospective cohort study using real-world data to evaluate...
4.
Tadokoro-Cuccaro R, Fisher B, Thankamony A, Ong K, Hughes I
Front Toxicol
. 2022 May;
4:884704.
PMID: 35499038
Paracetamol (acetaminophen) is the preferred antipyretic/analgesic for pregnant women as it is believed there are no adverse fetal effects at the recommended dose. However, emerging evidence suggests that intrauterine paracetamol...
5.
Tack L, van der Straaten S, Riedl S, Springer A, Holterhus P, Hornig N, et al.
Clin Endocrinol (Oxf)
. 2021 Oct;
96(2):165-174.
PMID: 34668586
Objective: Being born small for gestational age (SGA) is frequently associated with unexplained disorders of sex development (nonspecific DSD) in boys. Little is known about their future growth, puberty and...
6.
Stancampiano M, Lucas-Herald A, Bryce J, Russo G, Barera G, Balsamo A, et al.
Sex Dev
. 2021 Aug;
15(4):236-243.
PMID: 34350903
It is unclear whether testosterone replacement therapy (TRT) in adolescent boys, affected by a range of endocrine diseases that may be associated with hypogonadism, is particularly common. The aim of...
7.
Lucas-Herald A, Bryce J, Kyriakou A, Ljubicic M, Arlt W, Audi L, et al.
Eur J Endocrinol
. 2021 Mar;
184(6):791-801.
PMID: 33780351
Objectives: To determine trends in clinical practice for individuals with DSD requiring gonadectomy. Design: Retrospective cohort study. Methods: Information regarding age at gonadectomy according to diagnosis; reported sex; time of...
8.
Ali S, Bryce J, Haghpanahan H, Lewsey J, Tan L, Atapattu N, et al.
J Clin Endocrinol Metab
. 2020 Sep;
106(1):e192-e203.
PMID: 32995889
Background: Although congenital adrenal hyperplasia (CAH) is known to be associated with adrenal crises (AC), its association with patient- or clinician-reported sick day episodes (SDE) is less clear. Methods: Data...
9.
Lek N, Tadokoro-Cuccaro R, Hughes I
EBioMedicine
. 2018 Nov;
37:31.
PMID: 30385230
No abstract available.
10.
Lek N, Tadokoro-Cuccaro R, Whitchurch J, Mazumder B, Miles H, Prentice P, et al.
EBioMedicine
. 2018 Oct;
36:401-409.
PMID: 30316867
Background: PAIS exhibits a complex spectrum of phenotypes and pubertal outcomes. The paucity of reliable prognostic indicators can confound management decisions including sex-of-rearing. We assessed whether external masculinisation score (EMS)...